These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20224789)

  • 1. The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways.
    Courter D; Cao H; Kwok S; Kong C; Banh A; Kuo P; Bouley DM; Vice C; Brustugun OT; Denko NC; Koong AC; Giaccia A; Le QT
    PLoS One; 2010 Mar; 5(3):e9633. PubMed ID: 20224789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells.
    Chen YJ; Wei YY; Chen HT; Fong YC; Hsu CJ; Tsai CH; Hsu HC; Liu SH; Tang CH
    J Cell Physiol; 2009 Oct; 221(1):98-108. PubMed ID: 19475568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin increases lung cancer cells migration via activation of the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway.
    Fong YC; Liu SC; Huang CY; Li TM; Hsu SF; Kao ST; Tsai FJ; Chen WC; Chen CY; Tang CH
    Lung Cancer; 2009 Jun; 64(3):263-70. PubMed ID: 18996613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin mediates tumorigenic transformation of a preneoplastic murine cell line by suppressing anoikis: an Arg-Gly-Asp-dependent-focal adhesion kinase-caspase-8 axis.
    Hsieh YH; van der Heyde H; Oh ES; Guan JL; Chang PL
    Mol Carcinog; 2015 May; 54(5):379-92. PubMed ID: 24249517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer.
    Allan AL; George R; Vantyghem SA; Lee MW; Hodgson NC; Engel CJ; Holliday RL; Girvan DP; Scott LA; Postenka CO; Al-Katib W; Stitt LW; Uede T; Chambers AF; Tuck AB
    Am J Pathol; 2006 Jul; 169(1):233-46. PubMed ID: 16816376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of the thrombin cleavage domain of osteopontin mediates breast cancer cell adhesion, proteolytic activity, tumorgenicity, and metastasis.
    Beausoleil MS; Schulze EB; Goodale D; Postenka CO; Allan AL
    BMC Cancer; 2011 Jan; 11():25. PubMed ID: 21247495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma.
    Lin J; Myers AL; Wang Z; Nancarrow DJ; Ferrer-Torres D; Handlogten A; Leverenz K; Bao J; Thomas DG; Wang TD; Orringer MB; Reddy RM; Chang AC; Beer DG; Lin L
    Oncotarget; 2015 Sep; 6(26):22239-57. PubMed ID: 26068949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-directed mutagenesis of the arginine-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migration functions.
    Xuan JW; Hota C; Shigeyama Y; D'Errico JA; Somerman MJ; Chambers AF
    J Cell Biochem; 1995 Apr; 57(4):680-90. PubMed ID: 7542253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells.
    Tilli TM; Mello KD; Ferreira LB; Matos AR; Accioly MT; Faria PA; Bellahcène A; Castronovo V; Gimba ER
    Prostate; 2012 Nov; 72(15):1688-99. PubMed ID: 22495819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctive Prognostic Value and Cellular Functions of Osteopontin Splice Variants in Human Gastric Cancer.
    Hao C; Cui Y; Lane J; Jia S; Ji J; Jiang WG
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin promotes the progression of gastric cancer through the NF-κB pathway regulated by the MAPK and PI3K.
    Liu J; Liu Q; Wan Y; Zhao Z; Yu H; Luo H; Tang Z
    Int J Oncol; 2014 Jul; 45(1):282-90. PubMed ID: 24756245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha /IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways.
    Philip S; Kundu GC
    J Biol Chem; 2003 Apr; 278(16):14487-97. PubMed ID: 12473670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
    Mi Z; Guo H; Wai PY; Gao C; Kuo PC
    Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin as a target for cancer therapy.
    Johnston NI; Gunasekharan VK; Ravindranath A; O'Connell C; Johnston PG; El-Tanani MK
    Front Biosci; 2008 May; 13():4361-72. PubMed ID: 18508515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer.
    Shojaei F; Scott N; Kang X; Lappin PB; Fitzgerald AA; Karlicek S; Simmons BH; Wu A; Lee JH; Bergqvist S; Kraynov E
    J Exp Clin Cancer Res; 2012 Mar; 31(1):26. PubMed ID: 22444159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage.
    Yamaguchi Y; Shao Z; Sharif S; Du XY; Myles T; Merchant M; Harsh G; Glantz M; Recht L; Morser J; Leung LL
    J Biol Chem; 2013 Feb; 288(5):3097-111. PubMed ID: 23204518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin expression correlates with nuclear factor-κB activation and apoptosis downregulation in clear cell renal cell carcinoma.
    Matušan-Ilijaš K; Damante G; Fabbro D; Dorđević G; Hadžisejdić I; Grahovac M; Marić I; Spanjol J; Grahovac B; Jonjić N; Lučin K
    Pathol Res Pract; 2011 Feb; 207(2):104-10. PubMed ID: 21167650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin isoforms differentially promote arteriogenesis in response to ischemia via macrophage accumulation and survival.
    Lee GS; Salazar HF; Joseph G; Lok ZSY; Caroti CM; Weiss D; Taylor WR; Lyle AN
    Lab Invest; 2019 Mar; 99(3):331-345. PubMed ID: 29959420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A small interfering RNA targeting osteopontin as gastric cancer therapeutics.
    Gong M; Lu Z; Fang G; Bi J; Xue X
    Cancer Lett; 2008 Dec; 272(1):148-59. PubMed ID: 18694621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
    Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
    Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.